Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
lenvatinib
E7080-G000-201
NCT00784303
EU CTR 2007-005933-12
Differentiated Thyroid Cancer
Phase 2
 
No restrictions.
August 2015

Powered by ideaPoint, Inc.